A Retrospective Study on the Topographical and Etiological Aspects of Acute Flaccid Paralysis in Children in Kenitra Province, Morocco http://.www.doi.org/10.26538/tjnpr/v7i2.8

Main Article Content

Samira Jayche
Amr Loutfi
Sanae Sendaoui
Fatima Z. Talbi
Mohamed Lahmam
Ahmed Idrissi
Ahmed O.T. Ahami


The poliovirus was declared extinct in 1988. In Morocco, the most recent case of wild poliovirus (WPV) was reported in 1989. From 1994 to 2018, Kenitra's polio topographical and etiological epidemiology were described using WHO-recommended polio surveillance criteria. This retrospective descriptive study was conducted following WHO guidelines to examine the topographic and etiological factors that contribute to acute flaccid paralysis (AFP) in Kénitra, Morocco. Patients were recruited from several communities in the Kenitra province throughout a 25-year period, from January 1, 1994, to December 31, 2018. From 1994 to 2018, 76 cases of AFP were reported. The children ranged in age from 3 months to 14 years old; 52% were under the age of 5, and 58.67% were boys. At the time of paralysis onset, 57.33% of children had a fever, and 16% had asymmetric paralysis. The most common diagnosis was Guillain-Barré syndrome (59%), and 72% of sick children received more than three doses of the polio vaccine. Good coverage was obtained due to the national immunization program, as evidenced by the vaccination status. All cases were classified as non-polio AFP. There were no reports of poliovirus, and the vaccination status suggests that there was enough coverage due to the national immunization program. Morocco is vulnerable to the reintroduction of wild viruses due to its geographical location and constant intake of immigrants. This necessitates ongoing vaccination and surveillance efforts until the disease is declared eradicated.

Article Details

How to Cite
Jayche, S., Loutfi, A., Sendaoui, S., Talbi, F. Z., Lahmam, M., Idrissi, A., & Ahami, A. O. (2023). A Retrospective Study on the Topographical and Etiological Aspects of Acute Flaccid Paralysis in Children in Kenitra Province, Morocco: http://.www.doi.org/10.26538/tjnpr/v7i2.8. Tropical Journal of Natural Product Research (TJNPR), 7(2), 2352–2357. Retrieved from https://tjnpr.org/index.php/home/article/view/1647


Al Gunaid M, Lami F, Jarour N. A Collaborative Initiative to Strengthen Sustainable Public Health Capacity for Polio Eradication and Routine Immunization Activities in the Eastern Mediterranean Region. JMIR Public Health Surveill. 2019; 5(4):e14664

Ministry of health. Technical Guide for Integrated Disease Surveillance and Response in the Region. 2012

World Health Organization. Poliomyelitis. Poliomyelitis (who.int). 2019

Rhajaoui M. Bulletin de l’Institut National d’Hygiène. 2015; 4(Editorial).

World Health Organization. Polio: Vaccine Preventable Diseases Surveillance Standards. 2018

Baicus A. History of polio vaccination. WJV. 2012;1(4):108.

CDC. Updates on CDC’s Polio Eradication Efforts. CDC Global Health - Polio - Updates on CDC’s Polio Eradication Efforts; May 17, 2012

Donaldson LJ, Rutter PD. The Global Poliomyelitis Eradication Initiative: The Role of Diplomacy in Reaching" The Last 1%". In Pathways to Global Health: Case Studies in Global Health Diplomacy. 2017; 2:119-139.

Wassilak SG, Williams CL, Murrill CS, Dahl BA, Ohuabunwo C, Tangermann RH. Using acute flaccid paralysis surveillance as a platform for vaccine-preventable disease surveillance. JID. 2017;216(1):S293-S298.

Bouharrass A. Evaluation of the surveillance system for acute flaccid paralysis in Morocco. Ministry of Health of the Kingdom of Morocco, National Institute of Health Administration. End of studies dissertation. 2012

Doumtsop J G T, Khalef I, Diakite M L B, & Boubker N. AFP epidemiology and performance of the surveillance system in Mauritania from 2008 to 2012. Pan Af Med J. 2014; 18(1) :305.

Mier NL-PM de VT de, JM-C Fernandez-Martinez B. Vigilancia de la Parálisis Flácida Aguda y Vigilancia de Enterovirus. Plan de acción en España para la erradicación de la poliomielitis. 2017.

Masa-Calles J, Torner N, López-Perea N, de Mier M D V T, Fernández-Martínez B, Cabrerizo M, Gallardo-García V, Malo C, Margolles M, Portell M, Abadía N, Blasco A, García-Hernández S, Marcos H, Rabella N, Marín C, Fuentes A, Losada I, Gutiérrez J G, Martínez Ochoa E. Acute flaccid

paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015. Euro Surveill. 2018 ; 23 :1700423.

Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I, Onuekwusi, I. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect. Dis. 2020;20(1): 1-11.

Almoayed K A, Break A B, Al-Qassimi M, Assabri A, & Khader Y. The acute flaccid paralysis (AFP) surveillance system in Yemen, 2010-2015: descriptive study based on secondary data analysis JMIR Public Health Surveill. 2019;5(4):e14413.

Poorolajal J, Ghasemi S, Farahani LN, Hosseini AS, Bathaei SJ, Zahiri A. Evaluation of acute flaccid paralysis in hamadan, Iran from 2002 to 2009. EpiH, 2011, vol. 33. .

Sevencan F, Ertem M, Öner H, Aras-kılınç E, KöseOÖ, Demircioğlu S, Dilmen F, Eldemir R, Öncül M. Acute flaccidparalysis surveillance in southeasternTurkey 1999-2010. Turk J Pediatr. 2013;283‑91.

Raji IA, Abubakar AU, Ahmad A, Gidado S, Olorukooba AA, Lawal BB, Umeokonkwo CD & Balogun M. Evaluation of acute flaccid paralysis surveillance indicators in Sokoto state, Nigeria, 2012–2019: a secondary data analysis. BMC Publ Health, 2021, 21,1-9.

Manyanga, D., Byabamazima, C., Masvikeni, B., & Daniel, F. (2020). Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012-2019. Pan Af Med J, 36(1).

Abdel-Fattah A, Abdel-Hady E G, El-Masry R, Kanddeel A. Acute flaccid paralysis in North East Delta, Egypt: A retrospective analysis of prospectively collected surveillance data. J. Infect. Publ. Health. 2019; 12(5):714-719.

Tegegne AA, Fiona B, Shebeshi M E, Hailemariam F T, Aregay A K, Beyene B, Woyessa AB. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005-2015: progress and challenges. Pan Af Med J. 2017; 27(2):10.

Bitnun A and Yeh E. Acute flaccid paralysis and enteroviral infections. Curr. Infect. Dis Rep. 2018;20(9):1-15.

Lacerda RAJ, Galvão FE, Irochima PF, Pierdoná GF, Meneses RAC, Irami AF. Acute flaccid paralysis. GSC Biol Pharm Sci. 2019; 9(1):092-097.

Nasir NA, Khalaf YH, Al-Janabi, MK, Alhamdani FG, Ali AA, Mohammed K IA. Non-polio Enterovirus Isolation in children with acute Flaccid Paralysis in Iraq. P J M H S JUN 2020; 14(2):956-959

Habib KR. Polio Eradication in Bangladesh: Evaluation of AFP Surveillance Indicators, 2011-2015. IJI. 2017;5(1):11-19.

Zerriouh F, Khader Y, Qasem N, Abusal K, Iblan I, Ghaffari L, & Abdallat M. Evaluation of the Acute Flaccid Paralysis Surveillance System in Polio-Free Jordan, 2012-2016: Retrospective Secondary Analysis. JMIR Public Health Surveill. 2019;5(3):e14217.

Abdel-Fattah A, Abdel-Hady EG, El-Masry R, Kanddeel A. Acute flaccid paralysis in North East Delta, Egypt: A retrospective analysis of prospectively collected surveillance data. J. Infect. Public Health, 12(5):714-719.

Nishat H, & Saeed K M I. Descriptive Epidemiology of Acute Flaccid Paralysis Cases in Afghanistan, 2015-2018, IPROC. 2022; 8(1):e36530.

Ivanova O E, Shakaryan A K, Morozova N S, Vakulenko Y A, Eremeeva T P, Kozlovskaya L I, Lukashev A N. Cases of Acute Flaccid Paralysis Associated with Coxsackievirus A2: Findings of a 20-Year Surveillance in the Russian Federation. MDPI Microorganisms. 2022;10(1):112.

Most read articles by the same author(s)